SCHEMBL21585541

SCHEMBL21585541

CC(C)(C)c1cc(/C=C/c2ccccc2)cc(C=O)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.54
PTGS2 P35354 5/20 0.54
TNFRSF1A P19438 2/20 0.54
GABBR2 O75899 2/20 0.51
GABBR1 Q9UBS5 2/20 0.51
ALOX5 P09917 3/20 0.51
TTR P02766 1/20 0.47
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SIRT1 Q96EB6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21585538 1.00 PTGS1 (0.54) PTGS1PTGS2TNFRSF1AGABBR2GABBR1
SCHEMBL29850401 0.82 GABBR2 (0.53) PTGS1PTGS2GABBR2GABBR1MEN1
SCHEMBL570881 0.82 GABBR2 (0.53) PTGS1PTGS2GABBR2GABBR1MEN1
SCHEMBL6443271 0.78 ERN1 (0.51) CYP1A2CYP2C9
SCHEMBL28351505 0.78 GABBR2 (0.49) PTGS1PTGS2GABBR2GABBR1MEN1
SCHEMBL25176859 0.77 PTGS1 (0.55) PTGS1PTGS2TNFRSF1AALOX5TTR
SCHEMBL21428998 0.76 ERN1 (0.57) MAPTCYP1A2
SCHEMBL10328471 0.75 TNFRSF1A (0.40) PTGS2TNFRSF1AGABBR2GABBR1ALOX5
SCHEMBL570958 0.74 MAPT (0.52) PTGS1PTGS2TNFRSF1AGABBR2GABBR1
SCHEMBL15166601 0.74 MAPT (0.52) PTGS1PTGS2TNFRSF1AGABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11884639-B2 Preparation method for high optical indoxacarb intermediate SHANDONG JINGBO AGROCHEMICALS TECHNOLOGY CO., LTD. (CN) 2024-01-30 US claimed
EP-3805196-B1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE JINGBO AGROCHEMICALS TECH CO LTD (CN) 2022-03-30 EP claimed
US-20210363118-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE JINGBO AGROCHEMICALS TECHNOLOGY CO., LTD. (CN) 2021-11-25 US claimed
EP-3805196-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE Jingbo Agrochemicals Technology Co., Ltd (CN) 2021-04-14 EP claimed
US-11884639-B2 Preparation method for high optical indoxacarb intermediate SHANDONG JINGBO AGROCHEMICALS TECHNOLOGY CO., LTD. (CN) 2024-01-30 US disclosed
EP-3805196-B1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE JINGBO AGROCHEMICALS TECH CO LTD (CN) 2022-03-30 EP disclosed
US-20210363118-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE JINGBO AGROCHEMICALS TECHNOLOGY CO., LTD. (CN) 2021-11-25 US disclosed
EP-3805196-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE Jingbo Agrochemicals Technology Co., Ltd (CN) 2021-04-14 EP disclosed
CN-109485568-B Preparation method of high-optical indoxacarb intermediate 京博农化科技有限公司 2019-12-13 CN disclosed
WO-2019233211-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE 京博农化科技有限公司 (CN) 2019-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363118-A1 PREPARATION METHOD FOR HIGH OPTICAL INDOXACARB INTERMEDIATE IDO2, IDO1, DUOX2 PTGS1 1976/4885PTGS2 928/4885TNFRSF1A 3433/4885
US-11884639-B2 Preparation method for high optical indoxacarb intermediate IDO2, IDO1, DUOX2 PTGS1 1976/4885PTGS2 928/4885TNFRSF1A 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.